Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Parsons

Showing results (521-530 of 573) with videos related to

Pageof 58
Sort By:
Stroke|June 17, 2017
Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study)Thompson G Robinson, Xia Wang, Hisatomi Arima, et al.
Neurology|April 28, 2025
Effect of Thrombolytics on Delayed Reperfusion After Incomplete Thrombectomy: Target Trial EmulationAdnan Mujanovic, Vignan Yogendrakumar, Felix C Ng, et al.
The New England Journal of Medicine|February 18, 2016
Pioglitazone after Ischemic Stroke or Transient Ischemic AttackWalter N Kernan, Catherine M Viscoli, Karen L Furie, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|December 23, 2011
A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND)Henry Ma, Mark W Parsons, Soren Christensen, et al.
Stroke|November 27, 2023
Management of Poststroke Hyperglycemia: Results of the TEXAIS Randomized Clinical TrialChristopher F Bladin, Ngai Wah Cheung, Helen M Dewey, et al.
The Lancet. Neurology|May 7, 2022
Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trialAndrew Bivard, Henry Zhao, Leonid Churilov, et al.
Lancet (London, England)|February 8, 2026
Tenecteplase versus standard medical treatment for basilar artery occlusion within 24 h (TRACE-5): a multicentre, prospective, randomised, open-label, blinded-endpoint, superiority, phase 3 trialYunyun Xiong, Fana Alemseged, Zhixin Cao, et al.
Stroke|February 21, 2020
Melbourne Mobile Stroke Unit and Reperfusion Therapy: Greater Clinical Impact of Thrombectomy Than ThrombolysisHenry Zhao, Skye Coote, Damien Easton, et al.
Stroke|March 28, 2025
Association of Ischemic Core Hypodensity With Thrombectomy Treatment Effect in Large Core Stroke: A Secondary Analysis of the SELECT2 Randomized Controlled TrialVignan Yogendrakumar, Bruce C V Campbell, Hannah Johns, et al.
Neurology|November 14, 2024
Patterns and Clinical Implications of Hemorrhagic Transformation After Thrombolysis in Acute Ischemic Stroke: Results From the ENCHANTED StudyYanan Wang, Toshiki Maeda, Shoujiang You, et al.
Pageof 58

Showing results (521-530 of 573) with videos related to

Sort By:
Pageof 58
Stroke|June 17, 2017
Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study)Thompson G Robinson, Xia Wang, Hisatomi Arima, et al.
Neurology|April 28, 2025
Effect of Thrombolytics on Delayed Reperfusion After Incomplete Thrombectomy: Target Trial EmulationAdnan Mujanovic, Vignan Yogendrakumar, Felix C Ng, et al.
The New England Journal of Medicine|February 18, 2016
Pioglitazone after Ischemic Stroke or Transient Ischemic AttackWalter N Kernan, Catherine M Viscoli, Karen L Furie, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|December 23, 2011
A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND)Henry Ma, Mark W Parsons, Soren Christensen, et al.
Stroke|November 27, 2023
Management of Poststroke Hyperglycemia: Results of the TEXAIS Randomized Clinical TrialChristopher F Bladin, Ngai Wah Cheung, Helen M Dewey, et al.
The Lancet. Neurology|May 7, 2022
Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trialAndrew Bivard, Henry Zhao, Leonid Churilov, et al.
Lancet (London, England)|February 8, 2026
Tenecteplase versus standard medical treatment for basilar artery occlusion within 24 h (TRACE-5): a multicentre, prospective, randomised, open-label, blinded-endpoint, superiority, phase 3 trialYunyun Xiong, Fana Alemseged, Zhixin Cao, et al.
Stroke|February 21, 2020
Melbourne Mobile Stroke Unit and Reperfusion Therapy: Greater Clinical Impact of Thrombectomy Than ThrombolysisHenry Zhao, Skye Coote, Damien Easton, et al.
Stroke|March 28, 2025
Association of Ischemic Core Hypodensity With Thrombectomy Treatment Effect in Large Core Stroke: A Secondary Analysis of the SELECT2 Randomized Controlled TrialVignan Yogendrakumar, Bruce C V Campbell, Hannah Johns, et al.
Neurology|November 14, 2024
Patterns and Clinical Implications of Hemorrhagic Transformation After Thrombolysis in Acute Ischemic Stroke: Results From the ENCHANTED StudyYanan Wang, Toshiki Maeda, Shoujiang You, et al.
Pageof 58